Smartphone Screening for Eye Diseases

Launched by UNIVERSITY OF MICHIGAN · Mar 6, 2017

Keywords

ClinConnect Summary

This is an observational study (not a treatment trial) that is testing whether a smartphone camera attachment can take high-quality pictures of the back part of the eye (the retina) to screen for common eye diseases such as diabetic retinopathy, glaucoma, age-related macular degeneration, and retinopathy of prematurity. The researchers will compare the smartphone photos to traditional eye pictures taken in clinics and to the doctor’s eye exam. They also will test computer programs that try to diagnose eye disease from the photos, comparing their results to the doctors’ interpretations. The goal is to see if this easier, cheaper smartphone method can help more people get screened, especially where access to eye care is limited.

Who can participate? Adults, children, and older adults seen in ophthalmology clinics (and inpatients or in the operating room) at the University of Michigan, University of California, Berkeley, and Washington University. Inclusion criteria include any patient who has eye disease related to diabetes, glaucoma, age-related macular degeneration, or retinopathy of prematurity, or someone willing to participate. Exclusion criteria include having eye diseases outside this list. About 550 participants are planned. Participants will undergo smartphone fundus imaging in addition to standard imaging, with eye disease diagnoses reviewed by eye doctors; there is no treatment involved in the study, and results will help determine how accurate and helpful smartphone screening could be for future care. The study is currently enrolling and expected to finish around 2028.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any patient at least seen in the ophthalmology clinic with eye diseases as a result of diabetes, glaucoma, age related macular degeneration, retinopathy of prematurity, of who is willing to participate in the study.
• Exclusion Criteria:
• • Patients with eye diseases other than what is listed in inclusion criteria.